Replies to post #25823 on Grapefruit USA Inc (GPFT)

[nybuild1]

average down is probably the safer bet..... stop loss seems too risky at this point..... no?

[docmts2]

I never use ordered stop losses with biotech stocks. I use mental stops only and I had one in place here since the last run up because I never expected approval based on a particular date. What I wanted to sell was sold above 0.40. I'll be buying back well below 0.20.

For the gazillionth time those 30, 60, 90 day etc...deadlines are only guidelines and never set in stone. The FDA cares less about guidelines and more about getting it right so their decisions don't come back to burn them and rightfully so. Pumping expected approval dates benefits only those who are manipulating the price of the stock for short term trading while awaiting approval. I have nothing against those who trade short term, I do it myself, but manipulation is manipulation and I don't think many retail investors appreciate that practice.

So if we're done with the silly predictions I, for one, couldn't be happier. Or we can go for 180 days now. Who'll be the first on this board to make that prediction (complete with links to support this next bogus claim, of course)?

Finally, a credible biotech web consultant who watches biotech stocks and only biotech stocks for their livelihood predicted an October decision date. How did they come up with this estimated time frame? I suspect they have relationships with people in the know. Time will tell.